Isolation and molecular characterization of the Salmonella Typhimurium orphan phage Arash

Mohammad Hashem Yousefi1, Jeroen Wagemans2, Seyed Shahram Shekarforoush1

  • 1Department of Food Hygiene and Public Health, School of Veterinary Medicine, Shiraz University, Shiraz, 71946- 84471, Iran.

BMC Microbiology
|October 19, 2023
PubMed

Insights

A novel bacteriophage, named Arash, was isolated from hospital wastewater and characterized. This Salmonella Typhimurium phage shows potential as a therapeutic alternative to antibiotics due to its unique genomic and biological properties.

Area of Science:

  • Microbiology
  • Virology
  • Genomics

Background:

  • The rise of multidrug-resistant bacteria necessitates the exploration of alternative antimicrobial strategies.
  • Bacteriophages (phages) represent a promising alternative to conventional antibiotics.

Purpose of the Study:

  • To isolate and characterize a novel bacteriophage targeting Salmonella Typhimurium.
  • To evaluate the potential of this new phage as a therapeutic or biocontrol agent.

Main Methods:

  • Isolation of bacteriophage from hospital wastewater.
  • Morphological characterization using electron microscopy.
  • Host range determination and adsorption assays.
  • Replication cycle analysis (latent period, burst size).
  • Genomic sequencing and analysis (genome size, GC content, gene content).
  • Proteome analysis of mature phage particles.

Main Results:

  • A novel Salmonella Typhimurium phage, 'Arash', was isolated and identified as a myovirus.
  • Arash exhibits a restricted host range, a latent period of 65 min, and a burst size of 425 PFU/cell.
  • The phage possesses a 180,819 bp dsDNA genome with unique genetic features, suggesting a new species and genus ('Arashvirus').
  • No lysogeny, antibiotic resistance, or virulence genes were detected in Arash.
  • Proteome analysis identified 116 proteins, with 27 functionally assigned.

Conclusions:

  • The characterized phage 'Arash' is a novel species with distinct morphological, microbiological, and genomic properties.
  • Arash lacks undesirable genes, enhancing its safety profile for therapeutic applications.
  • The findings support the potential of Arash as a viable therapeutic agent or biocontrol strategy against Salmonella Typhimurium infections.